Trial of potential Ebola antiviral under way: WHO
The WHO has launched the first clinical trial for an experimental antiviral drug, obeldesivir, to treat individuals exposed to the Bundibugyo Ebola strain in the Democratic Republic of Congo. The trial aims to recruit 1,000 participants to test the drug's effectiveness as a post-exposure preventative measure.
Why it matters
As there are currently no approved treatments for this specific Ebola strain, this trial represents a critical effort to contain a deadly outbreak in a conflict-prone region.
Updated July 15, 2026, 7:01 a.m. | By AFP
The report is a straightforward summary of a WHO announcement and clinical trial status, utilizing wire service reporting.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in